Monte Rosa Therapeutics, Inc. Contracts & Agreements
32 Contracts & Agreements
- Business Finance (10 contracts)
- Business Operations (6)
- Human Resources (11)
- Intellectual Property (1)
- Real Estate (3)
- Uncategorized (1)
- Collaboration and License Agreement between Monte Rosa Therapeutics AG, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., dated as of October 16, 2023 (Filed With SEC on November 9, 2023)
- Securities Purchase Agreement, dated October 26, 2023 (Filed With SEC on October 26, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on October 26, 2023)
- Separation Agreement between the Registrant and Ajim Tamboli, effective as of August 8, 2023 (Filed With SEC on August 10, 2023)
- Agreement for Termination of Lease, by and between the Registrant and OPG MP Parcel Owner (DE) LLC, dated May 5, 2022 (Filed With SEC on May 11, 2022)
- Amended and Restated Employment Agreement between the Registrant and Philip Nickson, effective as of March 1, 2022 (Filed With SEC on March 29, 2022)
- Employment Agreement between the Registrant and Jullian Jones, effective as of June 28, 2021, as amended by the First Amendment to Employment Agreement, effective as of December... (Filed With SEC on March 29, 2022)
- Lease Agreement between the Registrant and B9 LS Harrison & Washington LLC, dated December 14, 2021 (Filed With SEC on March 29, 2022)
- Description of the Registrants Securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 29, 2022)
- 2021 Employee Stock Purchase Plan (Filed With SEC on June 21, 2021)
- Employment Agreement between the Registrant and Filip Janku, to be in effect upon the closing of this offering (Filed With SEC on June 21, 2021)
- Employment Agreement between the Registrant and John Castle, to be in effect upon the closing of this offering (Filed With SEC on June 21, 2021)
- Employment Agreement between the Registrant and Sharon Townson, to be in effect upon the closing of this offering (Filed With SEC on June 21, 2021)
- Employment Agreement between the Registrant and Owen Wallace, to be in effect upon the closing of this offering (Filed With SEC on June 21, 2021)
- Employment Agreement between the Registrant and Ajim Tamboli, to be in effect upon the closing of this offering (Filed With SEC on June 21, 2021)
- Employment Agreement between the Registrant and Markus Warmuth, to be in effect upon the closing of this offering (Filed With SEC on June 21, 2021)
- 2021 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on June 21, 2021)
- Form of Common Stock Certificate (Filed With SEC on June 21, 2021)
- Form of Underwriting Agreement (Filed With SEC on June 21, 2021)
- Second Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, dated March 11, 2021 (Filed With SEC on June 4, 2021)
- Lease Agreement, dated September 23, 2020, between OPG MP Parcel Owner (DE) LLC and the Registrant (Filed With SEC on June 4, 2021)
- Collaboration and Option Agreement, dated as of April 10, 2018, among Cancer Research Technology Limited, The Institute of Cancer Research: Royal Cancer Hospital and Monte Rosa... (Filed With SEC on June 4, 2021)
- License Agreement, dated as of April 10, 2018, among Cancer Research Technology Limited, The Institute of Cancer Research: Royal Cancer Hospital and Monte Rosa Therapeutics AG (Filed With SEC on June 4, 2021)
- Services Agreement, dated as of December 29, 2020, between Monte Rosa Therapeutics AG and the Registrant (Filed With SEC on June 4, 2021)
- Services Agreement, dated as of April 10, 2018, between Ridgeline Therapeutics GmbH and Monte Rosa Therapeutics AG (Filed With SEC on June 4, 2021)
- Contribution and Exchange Agreement, dated September 1, 2020, between certain shareholders of Monte Rosa Therapeutics AG and the Registrant (Filed With SEC on June 4, 2021)
- Contribution and Exchange Agreement, dated April 14, 2020, between certain shareholders of Monte Rosa Therapeutics AG and the Registrant (Filed With SEC on June 4, 2021)
- Form of Director Indemnification Agreement (Filed With SEC on June 4, 2021)
- Form of Officer Indemnification Agreement (Filed With SEC on June 4, 2021)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on June 4, 2021)
- 2020 Stock Option and Grant Plan, as amended, and forms of award agreements thereunder (Filed With SEC on June 4, 2021)
- Form of Common Stock Certificate (Filed With SEC on June 4, 2021)
